Proteasome inhibitors bortezomib and carfilzomib used for the treatment of multiple myeloma do not inhibit the serine protease HtrA2/Omi† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c6tx00220j
暂无分享,去创建一个
L. Dick | F. Wolenski | V. Csizmadia | C. Tsu | V. Kadambi | P. Hales | J. Senn | Pooja Shah | P. Fleming | Jingya Ma | Jiejin Chen